BR9908223A - Método para reduzir celulite na pele de mamìferos - Google Patents

Método para reduzir celulite na pele de mamìferos

Info

Publication number
BR9908223A
BR9908223A BR9908223-3A BR9908223A BR9908223A BR 9908223 A BR9908223 A BR 9908223A BR 9908223 A BR9908223 A BR 9908223A BR 9908223 A BR9908223 A BR 9908223A
Authority
BR
Brazil
Prior art keywords
cellulite
skin
mammals
reduce cellulite
reduce
Prior art date
Application number
BR9908223-3A
Other languages
English (en)
Inventor
Donald Lynn Bissett
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9908223A publication Critical patent/BR9908223A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/06—Preparations for care of the skin for countering cellulitis

Abstract

"MéTODO PARA REDUZIR CELULITE NA PELE DE MAMìFEROS". A presente invenção refere-se a um método para combater celulite ou os excessos de gordura localizada, o qual compreende administrar a uma pessoa que tem celulite ou excessos de gordura localizada uma quantidade emagrecedora do corpo de uma composição que contém niacinamida.
BR9908223-3A 1998-03-16 1999-03-12 Método para reduzir celulite na pele de mamìferos BR9908223A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7816398P 1998-03-16 1998-03-16
PCT/US1999/005407 WO1999047112A1 (en) 1998-03-16 1999-03-12 Method of reducing cellulite in mammalian skin

Publications (1)

Publication Number Publication Date
BR9908223A true BR9908223A (pt) 2000-10-24

Family

ID=22142324

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9908223-3A BR9908223A (pt) 1998-03-16 1999-03-12 Método para reduzir celulite na pele de mamìferos

Country Status (9)

Country Link
US (1) US5962482A (pt)
EP (1) EP1063963A1 (pt)
JP (1) JP2002506801A (pt)
KR (1) KR20010041902A (pt)
CN (1) CN1293562A (pt)
AU (1) AU3000499A (pt)
BR (1) BR9908223A (pt)
CA (1) CA2323179A1 (pt)
WO (1) WO1999047112A1 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767452B2 (en) 1997-02-20 2010-08-03 Kleinsek Don A Tissue treatments with adipocyte cells
ES2228146T3 (es) * 1998-12-01 2005-04-01 University Of Kentucky Research Foundation Uso de derivados de acido nicotinico para tratar el daño en el dna de celulas cutaneas.
US6444647B1 (en) 1999-04-19 2002-09-03 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
US20030224071A1 (en) * 1999-08-20 2003-12-04 Howard Murad Pharmaceutical compositions and methods for managing connective tissue ailments
AU6918700A (en) 1999-08-20 2001-03-19 Howard Murad Pharmaceutical compositions and methods for reducing the appearance of cellulite
US7658942B2 (en) * 2000-04-12 2010-02-09 The Procter & Gamble Company Cosmetic devices
JP2001302506A (ja) * 2000-04-21 2001-10-31 Pola Chem Ind Inc 好中球抑制剤及び抗掻痒用の皮膚外用剤
WO2003022239A2 (en) * 2001-09-07 2003-03-20 Western Holdings Llc Stable water in oil aminophylline emulsions
WO2005014806A2 (en) 2003-06-12 2005-02-17 Nucleonics, Inc. Conserved hbv and hcv sequences useful for gene silencing
FR2856294B1 (fr) * 2003-06-18 2005-08-05 Expanscience Lab Utilisation cosmetique d'une composition comprenant au moins une oxazoline, a titre de principe actif, comme amincissant et/ou pour prevenir et/ou traiter la cellulite
JP5015594B2 (ja) * 2003-06-23 2012-08-29 トランスファーマ メディカル リミテッド 化粧剤用経皮送達システム
CA2536026A1 (en) * 2003-08-22 2005-05-06 Nucleonics Inc. Eukariotic expression systems for expression of inhibitory rna in multiple intracellular compartments
JPWO2006011644A1 (ja) * 2004-07-27 2008-05-01 ビタミンＣ６０バイオリサーチ株式会社 セルライト抑制剤
JP4804467B2 (ja) 2004-08-23 2011-11-02 アルナイラム ファーマシューティカルズ， インコーポレイテッド 多重ｒｎａポリメラーゼｉｉｉプロモーター発現構築物
ES2362670T3 (es) 2004-09-24 2011-07-11 Alnylam Pharmaceuticals, Inc Orientación a intermedios de replicación de hebra no codificante de virus monocatenarios por arni.
ATE507293T1 (de) 2004-12-22 2011-05-15 Alnylam Pharmaceuticals Inc Zum gen-silencing geeignete konservierte hbv- und hcv-sequenzen
CN101217999A (zh) * 2005-07-08 2008-07-09 宝洁公司 用于哺乳动物皮肤和毛发美化的个人护理组合物及方法
US20070027152A1 (en) * 2005-07-27 2007-02-01 Clark Kathleen L Topical anti-pruritic compositions and methods of action of same
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
US7842725B2 (en) 2008-07-24 2010-11-30 Ecolab USA, Inc. Foaming alcohol compositions with selected dimethicone surfactants
US8802167B2 (en) * 2010-06-11 2014-08-12 Avon Products, Inc. Use of Eclipta prostrata and other PPAR-gamma inhibitors in cosmetics and compositions thereof
FR2967573B1 (fr) * 2010-11-23 2012-11-09 Rhodia Poliamida E Especialidades Ltda Kit cosmetique et utilisation pour ameliorer l'aspect de la peau
WO2013073894A1 (ko) * 2011-11-16 2013-05-23 (주)아모레퍼시픽 고농도의 카페인 및 니아신아미드를 함유하는 화장료 조성물
KR101979747B1 (ko) 2011-11-16 2019-05-17 (주)아모레퍼시픽 고농도의 카페인 및 니아신아미드를 함유하는 화장료 조성물
EP2893345B1 (en) * 2012-09-07 2017-11-08 Shiseido Company Ltd. Method of evaluating cellulite and method of evaluating cellulite-effective drug using fibulin-3 and/or sarcoglycan gamma as an indicator
ES2741656T3 (es) 2012-12-14 2020-02-11 Unilever Nv Niacinamida para inducir la generación de péptidos antimicrobianos
US9439841B2 (en) 2013-06-06 2016-09-13 Ecolab Usa Inc. Alcohol based sanitizer with improved dermal compatibility and feel
KR102120416B1 (ko) * 2013-12-20 2020-06-17 (주)아모레퍼시픽 고농도 카페인을 함유하는 조성물
FR3030253B1 (fr) * 2014-12-18 2018-03-02 Nutricos Technologies Composition pour ameliorer l'aspect cellulitique de la peau

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2222008A1 (en) * 1973-03-19 1974-10-18 Ffsa Mowing machine attachment with automatic operation - uses hydraulic system of tractor to raise and lower cutting bar
US4086922A (en) * 1976-09-08 1978-05-02 Burnis Henderson Method and apparatus for treating cellulite containing areas of the human body
US4829987A (en) * 1986-12-11 1989-05-16 Easy Tone Body Systems, Inc. Mineral body wrap combined with exercise for treating cellulite
LU87390A1 (fr) * 1988-11-17 1990-06-12 Oreal Utilisation du nicotinate d'alpha-tocopherol et/ou du nicotinate d'hexyle dans une composition cosmetique a action amincissante
FR2684300B1 (fr) * 1991-11-29 1994-03-11 Lvmh Recherche Composition cosmetique ou pharmaceutique, notamment dermatologique, destinee en particulier a favoriser la pigmentation de la peau ou des cheveux, contenant un extrait de ballote, et son procede de fabrication.
DE4401308C2 (de) * 1994-01-18 1997-01-30 Aerochemica Dr Deppe Gmbh Kosmetisches Mittel mit anticellulitischer Wirkung
US5885974A (en) * 1994-12-06 1999-03-23 Michael M. Danielov Therapeutic methods utilizing naturally derived bio-active complexes and delivery systems therefor
US5536499A (en) * 1995-02-24 1996-07-16 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions for reducing or preventing signs of cellulite
US5705170A (en) * 1995-10-24 1998-01-06 Plantech International, Inc. Herbal cellulite treatments

Also Published As

Publication number Publication date
EP1063963A1 (en) 2001-01-03
AU3000499A (en) 1999-10-11
US5962482A (en) 1999-10-05
WO1999047112A1 (en) 1999-09-23
CA2323179A1 (en) 1999-09-23
KR20010041902A (ko) 2001-05-25
CN1293562A (zh) 2001-05-02
JP2002506801A (ja) 2002-03-05

Similar Documents

Publication Publication Date Title
BR9908223A (pt) Método para reduzir celulite na pele de mamìferos
BR9810062A (pt) Composição cosmética contendo um agente alvejante, bem como uso de uma fonte de água em combinação com a mesma
BR9907090A (pt) Processos para redução do crescimento de cabelos estimulado por andrógenos em mamìferos e para aumento do crescimento de cabelos em mamìferos e do crescimento de cabelo do couro cabeludo de um ser humano
MX9704735A (es) Formulaciones para reducir irritacion de la piel y el uso de las mismas.
CO5150202A1 (es) Composicion de tisu facial y metodo para usarla para el secuestro de irritantes de la piel de la secrecion nasal
BR9903100A (pt) Composição anidra, processo de tratamento não terapêutico da pele e/ou do couro cabeludo e utilização de um silicone oxialquilenado substituìdo em (-(
MX9306239A (es) Composicion farmaceutica que forma un gel de lecitina in vivo para la liberacion mantenida de un compuesto biologicamente activo y procedimiento para la preparacion de la misma.
BR9909784A (pt) Conjunto de tratamento da pele.
DE69721766D1 (de) Neue arzneiformulierung
BR9806688A (pt) Composição cosmética e agente inibidor da melanogênese
BR9807577A (pt) Método para prevenir e retardar o inìcio da doença de alzheimer e sua composição
BR9806118A (pt) Processos para tratamento de pigmentação de pele
BR9612336A (pt) Instrumento e processo de medição para medir a dor existente em uma parte arbitrária do corpo de um paciente, ou a náusea de um paciente.
BR0315716A (pt) Composição e método para o tratamento dos cabelos
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
PT920323E (pt) Nova utilizacao de fosfolipidos de origem animal em terapeutica e/ou dietetica
BR0306306A (pt) Composição contendo extrato de matricária e uso desta
GR890100404A (el) Καλλυντικες συνθεσεις και συνθεσεις περιποιησεων του δερματος
ES2084371T3 (es) Composiciones cosmeticas que contienen un extracto de eclipta alba.
SE8602241D0 (sv) Hudregenererande och hydratiserande kosmetiska kompositioner och forfarande for framstellning av den aktiva ingrediensen
WO1998057620A3 (en) Inositol for modulation of immune response
BR0010515A (pt) Sistema terapêutico de ministração transdérmica, processo para mascarar um odor desagrádavel e uso de um óleo essencial em um sistema terapéutico de ministração transdérmica
FR2631234B1 (fr) Composition cosmetique ou dermatologique, notamment a action amincissante ou anti-cellulitique contenant des extraits de cola sous forme libre ou sous forme liposomale
PT817625E (pt) Composicoes para o tratamento de pele fotodanificada, compreendendo um antagonista de rar-alfa e um retinoide multi-selectivo
BR9814333A (pt) Composição para axilas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1962 DE 12/08/2008.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/44 (2006.01), A61K 8/67 (2006.0